Recro Pharma, Inc. Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. for December 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2020 | REPH | Recro Pharma, Inc. | SCP Vitalife Partners (Israel) ... | 10% Owner | Sell | S | 3.17 | 18,830 | 59,691 | 701,017 | 719.8 K to 701 K (-2.62 %) |
| Dec 28 2020 | REPH | Recro Pharma, Inc. | SCP Vitalife Partners II LP | 10% Owner | Sell | S | 3.17 | 56,375 | 178,709 | 2,097,938 | 2.2 M to 2.1 M (-2.62 %) |
| Dec 22 2020 | REPH | Recro Pharma, Inc. | SCP Vitalife Partners (Israel) ... | 10% Owner | Sell | S | 3.03 | 6,208 | 18,813 | 719,847 | 726.1 K to 719.8 K (-0.86 %) |
| Dec 22 2020 | REPH | Recro Pharma, Inc. | SCP Vitalife Partners II LP | 10% Owner | Sell | S | 3.03 | 18,587 | 56,326 | 2,154,313 | 2.2 M to 2.2 M (-0.86 %) |
| Dec 18 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 3.03 | 116,505 | 353,010 | 116,505 | |
| Dec 18 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 79,208 | 0 | 131,983 | 52.8 K to 132 K (+150.09 %) |
| Dec 18 2020 | REPH | Recro Pharma, Inc. | ENLOE J DAVID JR | Chief Executive Off ... | Option Exercise | A | 3.03 | 194,175 | 588,350 | 194,175 | |
| Dec 18 2020 | REPH | Recro Pharma, Inc. | ENLOE J DAVID JR | Chief Executive Off ... | Grant | A | 0.00 | 132,013 | 0 | 151,815 | 19.8 K to 151.8 K (+666.66 %) |
| Dec 18 2020 | REPH | Recro Pharma, Inc. | ENLOE J DAVID JR | Chief Executive Off ... | Grant | A | 0.00 | 19,802 | 0 | 19,802 | 0 to 19.8 K |
| Dec 09 2020 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 2.30 | 7,611 | 17,505 | 52,775 | 60.4 K to 52.8 K (-12.60 %) |
| Dec 09 2020 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 2.30 | 34,128 | 78,494 | 207,066 | 241.2 K to 207.1 K (-14.15 %) |